Clinical Trials

Text Size A A

E-Mail to a Friend






secret  Click to Play Audio


Breast Cancer

The Seattle Cancer Care Alliance Breast Cancer Research Program has a multidisciplinary approach to cancer research focusing on the diagnosis and treatment of cancer with novel imaging and cancer treatment agents. We put particular emphasis on imaging trials that meaure the ability of MRIs and PET imaging to predict response to treatment. We also explore targeted therapy including those treatments aimed at specific processes of cancer cell growth, division or life cycle or, in some cases, the blood vessels nourishing a tumor.

Click here to view all the breast cancer trials that are currently recruiting patients at SCCA.

Our current high priority trials include:

Targeted Therapy

For newly diagnosed patients:

  • Pfizer Sutent (6488)
    A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Maleate (Sutent) in Combination With Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF as Neoadjuvant Chemotherapy for Locally Advanced or Inflammatory Breast Cancer

For patients with metastatic disease:

Immune-based Therapy

For patients with metastatic disease:

Imaging Studies

For patients with newly diagnosed disease:

For patients with metastatic disease:

Supportive Care Studies

Our faculty also participate in cooperative group trials through the Southwest Oncology Group (SWOG), the American College of Surgeons Oncology Group (ACOSOG) and the American College of Imaging Network (ACRIN).